// App-Quantinova.ai

P471 : Association of vedolizumab levels with clinical and biochemical markers of inflammation during maintenance therapy in inflammatory bowel disease

Researchers

Presenter

  • N Plevris

Principal Investigators

  • G R Jones

  • P W Jenkinson

  • C S Chuah

  • M Lyons

  • L M Merchant

  • R J Pattenden

  • I D Arnott

  • C W Lees

Medical Centers

  • Western General Hospital NHS Lothian,Edinburgh, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

Biomarkers

  • C reactive protein

Drug/Treatment

  • Entyvio

Outcome

  • N/A


Study Design

  • Prospective

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A